Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-24 @ 2:15 PM
NCT ID:
NCT04684095
Eligibility Criteria:
Inclusion Criteria:
* Patients must have informed consent form (ICF) signed for the study
* Patients must be ≥18 years old when signing the ICF
* Histologically or cytologically-diagnosed unresectable metastatic colorectal cancer
* Patients must receive bevacizumab combined with chemotherapy for first-line systemic treatment
* The researcher believes that the patient is capable of implementing the research protocol
Exclusion Criteria:
* Patients has participated in any clinical trial in the past 4 weeks
* Patients is currently or about to participate in a clinical trial
* Patients with other malignant tumors (except carcinoma in situ)
* Patients with lung metastases only
* Patients with evidence of any serious or uncontrolled systemic disease, including but not limited to: unstable or decompensated respiratory, heart, liver or kidney disease, HIV infection, uncontrolled hypertension, diabetes, severe arrhythmia, massive hemorrhagic activity, etc
* Patients with history of alcohol or drug abuse
* According to the researcher's judgment, the possibility of inclusion is low (including inability to understand the study requirements, poor compliance, weakness, inability to ensure that the protocol can be implemented as required, etc.), or the researcher believes that other factors are not suitable for this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04684095
Study Brief:
Protocol Section:
NCT04684095